Описание
Summary of clinical trial designs and regulatory considerations for cosmeceutical hair regrowth products.
Fig. 8
DiagramSource Paper
Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mechanistic Breakthroughs and Industrial Prospects Driven by Multidisciplinary Collaborative Innovation.Cite This Figure
 > Source: Xuexue Pan et al. "Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mecha." *Aesthetic plastic surgery*, 2025. PMID: [40790388](https://pubmed.ncbi.nlm.nih.gov/40790388/)
<figure> <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12594698/bin/266_2025_5077_Fig8_HTML.jpg" alt="Summary of clinical trial designs and regulatory considerations for cosmeceutical hair regrowth products." /> <figcaption>Fig. 8. Summary of clinical trial designs and regulatory considerations for cosmeceutical hair regrowth products.<br> Source: Xuexue Pan et al. "Technological Advances in Anti-hair Loss and Hair Regrowth Cosmeceuticals: Mecha." <em>Aesthetic plastic surgery</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40790388/">40790388</a></figcaption> </figure>
Связанные доказательства
A
Finasteride для Андрогенетическая алопеция
A
Оценка A · 206 исследований
Minoxidil для Alopecia Areata
A
Оценка A · 122 исследований
Minoxidil для Телогеновый эффлувиум
A
Оценка A · 66 исследований
Minoxidil для Андрогенетическая алопеция
A
Оценка A · 299 исследований
Микронидлинг для Alopecia Areata
A
Оценка A · 34 исследований
Микронидлинг для Андрогенетическая алопеция
B
Оценка A · 62 исследований
Железо для Телогеновый эффлувиум
Оценка B · 62 исследований